403
Participants
Start Date
October 31, 2013
Primary Completion Date
January 31, 2017
Study Completion Date
January 31, 2017
Drug: EVP-6124
Placebo
Tucson
Little Rock
Culver City
Downey
Los Alamitos
Los Angeles
Oceanside
Orange
Norwich
Bradenton
Gainesville
Hallandale
Hialeah
Jacksonville
Leesburg
Miami
Sarasota
Sunrise
West Palm Beach
Atlanta
Elk Grove Village
Springfield
Newton
Hattiesburg
Albuquerque
Albany
Cedarhurst
New Hyde Park
New York
Staten Island
Charlotte
Durham
Shaker Heights
Oklahoma City
Abington
Jenkintown
Plains
East Providence
Houston
Salt Lake City
Charlottesville
Richland
Buenos Aires
Rosario
Santa Fe
Box Hill
Caulfield South
Halifax
London
Québec
Brno
Choceň
Hradec Králové
Prague
Richnov Nad Kneznou
Bordeaux
Caen
Paris
Homburg
Mittweida
München
Westerstede
Ancona
Milan
Saltillo
Amsterdam
S'Hertogenbosch
The Hague
Durban
Bellville
George
Incheon
Seoul
Madrid
Salamanca
West End
Bath
Glasgow
Isleworth
Northampton
Penarth
Lead Sponsor
FORUM Pharmaceuticals Inc
INDUSTRY